Fulvestrant 250mg/5ml solution for injection pre-filled syringes
NHS hospitals in England used £19,995,767 of indicative cost of Fulvestrant 250mg/5ml solution for injection pre-filled syringes in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 4.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Fulvestrant 250mg/5ml solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Fulvestrant 250mg/5ml solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £1,138,593 |
| The Royal Marsden Nhs Foundation Trust | £836,901 |
| The Clatterbridge Cancer Centre Nhs Ft | £709,433 |
| Univ Hpl B/Ham Nhs Foundation Trust | £646,221 |
| East And North Hertfordshire Nhs Trust | £421,063 |
| Sheffield Teaching Hospitals Nhs Trust | £408,002 |
| Derby Teaching Hospitals Nhs Found Trust | £389,195 |
| Nottingham University Hospitals Trust | £387,628 |
| Worcestershire Acute Hpls Nhs Trust | £372,478 |
| Leeds Teaching Hpls Nhs Trust | £357,328 |
The primary-care picture
Fulvestrant is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Fulvestrant medicine page.